Articles On Micro-X (ASX:MX1)

This content is created by Smallcaps Authors. [Author : Imelda Cotton] South Australian x-ray technology developer Micro-X (ASX: MX1) has confirmed its subsidiary company Micro-X Inc has been awarded a $21 million contract extension with...

At noon, the S&P/ASX 200 is 0.14 per cent higher at 7,324. Suncorp has confirmed that the Australian Competition & Consumer Commission (ACCC) has requested additional time to review ANZ's merger with Suncorp. The ACCC asked for the...

  Micro-X (ASX:MX1) extends contract with U.S. DHS to test self-screening modules at an airport. In response, Micro-X Inc. Chief Executive Officer of Americas and Chief Scientist, Brian Gonzales, commented: “This contract extension fully fu...

24 Jul 2023 - A snapshot of the stocks on the move, featuring Micro-X (ASX:MX1), European Metals (ASX:EMH) and Tamboran Resources (ASX:TBN).

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

ASX health stocks have fallen in the past five days in line with broader markets Mach7 wins a US$60 million Veterans contract – the most significant in its history Neuren completes recruitment for Phase II trial of NNZ-2591 in Phelan-McDer...

Brisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “game changer” We look at the best and worst performing ASX biotechs over the past month   The world is anticipating a “game changer” as Brisba...

Small cap health stocks are not known to pay dividends But there’s a handful of such stocks on the ASX that do pay dividends We look at the best and worst performing ASX biotechs over the past week   When we talk about dividend-paying hea...

The ASX tech sector rallied 11.6% in May and is up 16.94% YTD, surpassing the S&P ASX 200 Audio Pixels tops May ASX tech winners following AGM comments by CEO and chairman Archer Materials performs strongly in May after key global part...

ASX health stocks outperforming the broader market but remain flattish for week Several ASX health plays undertaking capital raising with more expected in H2 CY23 Micro-X successfully tests its Argus bomb detection unit opening door to US$...

The ASX200 shed 8.1 points on Tuesday or 0.11 per cent, just one day after its strongest advance since mid-April. The real estate and energy sectors were the biggest drags on the market, each down around 1 per cent. In the red Ma...

ASX benchmark ends the day flat, but not for lack of trying to rise. Or fall Tech stocks fell hard at first light, but rallied to finish the day well out in front Despite a short-lived challenge from Audio Pixels, Micro-X has won the day i...

Micro-X Argus bomb detection unit successfully field tested opening door to US$1.8 billion market The device removes need for a bomb disposal technician to get up close to a suspect package Argus has attracted attention of key defence and...

ASX health stocks fall 0.8% in the past five days in line with broader markets following latest rate hike Investors rewarding health stocks with near term catalysts in 2023, including Neuren and Impedimed Health imaging stock Volpara recor...

RBA Board kicks the nation in the goolies again, demanding another 25 basis points Investors seemingly caught by surprise, tanking the market in a matter of minutes Pinnacle Minerals let off the leash by the ASX, but still ahead of the gam...

Artificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discovery Telix delivers first quarterly revenue of $100 million   Moody’s Analytics’ chief economist, Mark Zandi, said the healthcare industry’s...

What’s wrong with our tadpoles, gentlemen? According to local fertility expert Prof John Aitken, sperm counts have roughly halved over the last 50 years and about 20 per cent of men shoot blanks. No-one’s sure why, but possible reasons incl...

ASX health stocks fall 0.9% in the past five days Healius receives a $1.52 billion takeover offer from Australian Clinical Labs Pharmaceutical wholesaler Sigma reports improved performance for the financial year Healthcare and life scien...

The medical imaging market size globally is forecast to reach $68.8 Billion by 2030 Several ASX health imaging stocks are establishing strong footholds and niches in sector Micro-X branching out from the medical sphere with its bomb detect...

ASX climbed as high as +1.3%, easing slightly to close up 0.9%. XEC Emerging Companies and Goldies duke it out to see who can close flattest. Investors are set to pocket $35 billion in dividends between now and EOFY.   Do Not Adjust Your...

ASX health stocks fall 1.87% in the past five days as reporting season ends Healius moves to a statutory loss of ~$29 million following reduced demand for Covid-19 testing Catalysts in next few months for several ASX health stocks which co...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((ABY)) - Adore Beauty ((AIM)) - Ai-Media Technologies ((AGI)) - Ainsworth Game Technology ((ART)) - Airtasker ((AKE)) - Allkem ((APM)) - APM Human Services International...

ASX health stocks rise 2.27% this week after finishing up 3.9% in January in strong start to 2023 Mach 7 posts a record quarter in sales after landing its largest ever contract in December EBR System’s pivotal trial into WiSE on schedule,...

The FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have grown exponentially in the marketplace We take a look at what it all means for the cannabis industry   The US FDA announced last week that:...

Japanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based device Which ASX healthcare companies also have smartphone-based products? A quick look at the best and worst ASX healthcare stocks over the past...

The ASX Health sector has fallen ~1.5% in its first trading week of 2023 Mach7  has surged after landing its largest ever customer contract Proteomics gets US approval for PromarkerD test for diabetic kidney disease Healthcare and life sc...

The long and short of 2022 is that it was a frustrating period for the Australian biotech sector but one with its fair share of rewards as the sector’s exponents furthered worthy drugs, diagnostics, devices and doodahs. For the sixth year,...

ASX health stocks have been out of favour this year with rotation away from growth to value sector Morgan’s Scott Power said a lot of biotechs aren’t able to convert their complex science into layman’s terms Hot money going to lithium and...

It’s quarterlies season again as the ASX market announcements page becomes increasingly flooded with earnings lodgements. To save you the trouble of trudging through it all, we’ve wrapped up the highlights from some of the reports that caug...

We take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO stocks from 2021 have gained since listing We also look at the best and worst performing ASX stocks over the past month   There were 191 ASX IPOs in...

ShareCafeWebinar Recap – EZZ, ELS, MX1 & QXR Catch up on the full webinar presentations from EZZ Life Sciences (ASX: EZZ), Elsight (ASX: ELS), Micro-X (ASX: MX1) & QX Resources (ASX: QXR) Webinar Recap – EZZ, ELS, MX1 & QXRComp...

ShareCafeMicro-X (ASX: MX1) – Webinar Presentation Peter Rowland – Managing Director – Mirco-X is a leading global revolution company in medical and security imaging products, which designs, develops, and manufactures ultra-lightweight car...

The ASX will open more than 1% lower on Monday Wall Street tumbled again on Friday on recession fears UK announced historic tax cuts Local shares are set to open much lower on Monday. At 8am AEST, the ASX 200 October futures contract is p...

ShareCafeEvening Report: 19 September, 2022 by Paul Sanger   At the closing bell, the S&P/ASX 200 was 0.28 per cent or 19.20 points lower at 6719.90. Futures The Dow Jones futures are pointing to a fall of 118 points. The S&P 500 fu...

The Micro-X Ltd (ASX: MX1) share price exploded today on news of a $15 million investment. Micro-X shares surged 37% from 13.5 cents to 18.5 cents before retreating. The company’s shares finished the day up 26%. Let’s take a look at what...

The ASX 200 is vacillating Small caps are down over 1.3% Demetallica is a great name and it’s up 40% on takeover talk   The benchmark ASX 200 is flat as on Monday. The ASX Emerging Companies (XEC) index has lost 1.3%. REITs and Gold are h...

ShareCafeLunch Report: 19 September, 2022 by Paul Sanger   At noon, the S&P/ASX 200 is 0.10 per cent or 7.00 points higher at 6746.10. The SPI futures are pointing to a rise of 5 points. Best and worst performers The best-performing sec...

ShareCafeStocks of the Hour: 19 September, 2022                    Australian hi-tech company Micro-X Ltd (ASX:MX1) a leader in x-ray technology for health and security markets globally, is pleased to announce a strategic collaboratio...

19 Sep 2022 - A snapshot of the stocks on the move featuring Micro-X (ASX:MX1), IVE Group (ASX:IGL) and Origin Energy (ASX:ORG).

ASX 200 sinks 2% Small caps get crushed, down 2.5%  Region, AUD and miners sink on weaker China activity   The local market is being dragged to hell by mining, materials and gold stocks, which are down between 4% and 5%. The S&P/ASX...

The RangeHawk drone has a whopping 40m wingspan and is set to test hypersonic weapons  DroneShield secures $2m contract from European Government customer for its counterdrone tech Aerospace player Quickstep has had to expand its Geelong f...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((AMS)) - Atomos ((ATA)) - Atturra ((BST)) - Best & Less ((BTH)) - Bigtincan Holdings ((BBT)) - BlueBet Holdings ((BVS)) - Bravura Solutions ((BUB)) - Bubs Australia (...

US FDA approves the first clinical trial using naturally derived psychedelic drugs It could open possibilities for other clinical trials to follow suit Best and worst biotechs over the past month In a ground-breaking development, the US F...

A recent research reveals which biotech segments VCs are ploughing billions of dollars into We list the ASX companies that are operating within those thematics We also list the best and worst ASX biotech performers over the past week and m...

114 tech stocks were trading down for the month of June 11 stocks flatlined and only 22 were in the green The biggest losers were iSYNERGY, Icetana and Eroad   Wowzers. Even by tech stocks standards, June was a bit of a shocker, with the...

Avita Medical makes spray on skin for burns and soft tissue injuries HITIQ’s concussion tech is popular for athletes and sports teams PainChek’s smartphone app can tell if babies or older Aussies are in pain There’s a plethora of biotech...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Google engineer reckons chatbot has become sentient Xtek sends $9.5m of specialist ballistic products to secret US customer Micro-X nabs new US distributor for its mobile Rover x-ray product   Google engineer Blake Lemoine has been sent o...

Dark clouds continue to hover over ASX health stocks Health imaging company Volpara’s FY22 results in line with expectations Fight for fertility company Virtus enters another round Healthcare and life sciences expert Scott Power – a senio...

Successful first stage design milestone for Micro-X Passenger Self screening station – Unlocks $0.7m second phase of work ADELAIDE, Australia and SEATTLE, May 24, 2022 /PRNewswire/ — Australian hi-tech company Micro-X Ltd (ASX:MX1) (Micro-X...